Safety, pharmacokinetic and pharmacodynamic results from dose escalation of SAR439459, a TGFb inhibitor, as monotherapy or in combination with cemiplimab in a phase 1/1b study.
SAR-439459;Cemiplimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Safety, pharmacokinetic and pharmacodynamic results from dose escalation of SAR439459, a TGFb inhibitor, as monotherapy or in combination with cemiplimab in a phase 1/1b study. ### Output: SAR-439459;Cemiplimab